105 related articles for article (PubMed ID: 20042190)
1. Increased macrophage cholesterol biosynthesis and decreased cellular paraoxonase 2 (PON2) expression in Delta6-desaturase knockout (6-DS KO) mice: beneficial effects of arachidonic acid.
Rosenblat M; Volkova N; Roqueta-Rivera M; Nakamura MT; Aviram M
Atherosclerosis; 2010 Jun; 210(2):414-21. PubMed ID: 20042190
[TBL] [Abstract][Full Text] [Related]
2. Pomegranate juice (PJ) consumption antioxidative properties on mouse macrophages, but not PJ beneficial effects on macrophage cholesterol and triglyceride metabolism, are mediated via PJ-induced stimulation of macrophage PON2.
Rosenblat M; Volkova N; Aviram M
Atherosclerosis; 2010 Sep; 212(1):86-92. PubMed ID: 20537330
[TBL] [Abstract][Full Text] [Related]
3. Paraoxonase 2 (PON2) decreases high glucose-induced macrophage triglycerides (TG) accumulation, via inhibition of NADPH-oxidase and DGAT1 activity: studies in PON2-deficient mice.
Meilin E; Aviram M; Hayek T
Atherosclerosis; 2010 Feb; 208(2):390-5. PubMed ID: 19748094
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase 2 attenuates macrophage triglyceride accumulation via inhibition of diacylglycerol acyltransferase 1.
Rosenblat M; Coleman R; Reddy ST; Aviram M
J Lipid Res; 2009 May; 50(5):870-9. PubMed ID: 19091699
[TBL] [Abstract][Full Text] [Related]
5. Macrophage NADPH oxidase activation, impaired cholesterol fluxes, and increased cholesterol biosynthesis in diabetic mice: a stimulatory role for D-glucose.
Hayek T; Kaplan M; Kerry R; Aviram M
Atherosclerosis; 2007 Dec; 195(2):277-86. PubMed ID: 17258748
[TBL] [Abstract][Full Text] [Related]
6. Urokinase plasminogen activator upregulates paraoxonase 2 expression in macrophages via an NADPH oxidase-dependent mechanism.
Fuhrman B; Khateeb J; Shiner M; Nitzan O; Karry R; Volkova N; Aviram M
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1361-7. PubMed ID: 18436804
[TBL] [Abstract][Full Text] [Related]
7. Decreased macrophage paraoxonase 2 expression in patients with hypercholesterolemia is the result of their increased cellular cholesterol content: effect of atorvastatin therapy.
Rosenblat M; Hayek T; Hussein K; Aviram M
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):175-80. PubMed ID: 14592851
[TBL] [Abstract][Full Text] [Related]
8. Paraoxonase 2 (PON2) expression is upregulated via a reduced-nicotinamide-adenine-dinucleotide-phosphate (NADPH)-oxidase-dependent mechanism during monocytes differentiation into macrophages.
Shiner M; Fuhrman B; Aviram M
Free Radic Biol Med; 2004 Dec; 37(12):2052-63. PubMed ID: 15544923
[TBL] [Abstract][Full Text] [Related]
9. Macrophage endoplasmic reticulum (ER) proteins and reducing elements stabilize paraoxonase 2 (PON2).
Rosenblat M; Volkova N; Aviram M
Atherosclerosis; 2010 Dec; 213(2):408-14. PubMed ID: 21036357
[TBL] [Abstract][Full Text] [Related]
10. Injection of paraoxonase 1 (PON1) to mice stimulates their HDL and macrophage antiatherogenicity.
Rosenblat M; Volkova N; Aviram M
Biofactors; 2011; 37(6):462-7. PubMed ID: 22162319
[TBL] [Abstract][Full Text] [Related]
11. A biphasic U-shape effect of cellular oxidative stress on the macrophage anti-oxidant paraoxonase 2 (PON2) enzymatic activity.
Shiner M; Fuhrman B; Aviram M
Biochem Biophys Res Commun; 2006 Oct; 349(3):1094-9. PubMed ID: 16970920
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice.
Rozenberg O; Rosenblat M; Coleman R; Shih DM; Aviram M
Free Radic Biol Med; 2003 Mar; 34(6):774-84. PubMed ID: 12633754
[TBL] [Abstract][Full Text] [Related]
13. Macrophage paraoxonase 2 (PON2) expression is up-regulated by pomegranate juice phenolic anti-oxidants via PPAR gamma and AP-1 pathway activation.
Shiner M; Fuhrman B; Aviram M
Atherosclerosis; 2007 Dec; 195(2):313-21. PubMed ID: 17292903
[TBL] [Abstract][Full Text] [Related]
14. Triglyceride accumulation in macrophages upregulates paraoxonase 2 (PON2) expression via ROS-mediated JNK/c-Jun signaling pathway activation.
Rosenblat M; Volkova N; Paland N; Aviram M
Biofactors; 2012; 38(6):458-69. PubMed ID: 23047827
[TBL] [Abstract][Full Text] [Related]
15. Leucine supplementation attenuates macrophage foam-cell formation: Studies in humans, mice, and cultured macrophages.
Grajeda-Iglesias C; Rom O; Hamoud S; Volkova N; Hayek T; Abu-Saleh N; Aviram M
Biofactors; 2018 May; 44(3):245-262. PubMed ID: 29399895
[TBL] [Abstract][Full Text] [Related]
16. HDL3 stimulates paraoxonase 1 antiatherogenic catalytic and biological activities in a macrophage model system: in vivo and in vitro studies.
Rosenblat M; Volkova N; Aviram M
Biofactors; 2014; 40(5):536-45. PubMed ID: 25230879
[TBL] [Abstract][Full Text] [Related]
17. Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice.
Rozenberg O; Shih DM; Aviram M
Atherosclerosis; 2005 Jul; 181(1):9-18. PubMed ID: 15939049
[TBL] [Abstract][Full Text] [Related]
18. Paraoxsonase2 (PON2) and oxidative stress involvement in pomegranate juice protection against cigarette smoke-induced macrophage cholesterol accumulation.
Rom O; Aviram M
Chem Biol Interact; 2016 Nov; 259(Pt B):394-400. PubMed ID: 27163848
[TBL] [Abstract][Full Text] [Related]
19. High glucose concentration increases macrophage cholesterol biosynthesis in diabetes through activation of the sterol regulatory element binding protein 1 (SREBP1): inhibitory effect of insulin.
Kaplan M; Kerry R; Aviram M; Hayek T
J Cardiovasc Pharmacol; 2008 Oct; 52(4):324-32. PubMed ID: 18791464
[TBL] [Abstract][Full Text] [Related]
20. Macrophage paraoxonase 2 (PON2) expression is upregulated by unesterified cholesterol through activation of the phosphatidylinositol 3-kinase (PI3K) pathway.
Shiner M; Fuhrman B; Aviram M
Biol Chem; 2007 Dec; 388(12):1353-8. PubMed ID: 18020951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
